Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 46

1.

Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances.

Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO; FREEDOM Study Group.

Clin J Am Soc Nephrol. 2011 May;6(5):1049-56. doi: 10.2215/CJN.10451110. Epub 2011 Mar 17.

2.

Non-pharmacological management of periodic limb movements during hemodialysis session in patients with uremic restless legs syndrome.

Giannaki CD, Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Patramani G, Lavdas E, Liakopoulos V, Koutedakis Y, Stefanidis I.

ASAIO J. 2010 Nov-Dec;56(6):538-42. doi: 10.1097/MAT.0b013e3181f1cc04.

PMID:
21245801
3.

Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome.

Shinno H, Oka Y, Otsuki M, Tsuchiya S, Mizuno S, Kawada S, Innami T, Sasaki A, Hineno T, Sakamoto T, Inami Y, Nakamura Y, Horiguchi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):522-6. doi: 10.1016/j.pnpbp.2010.02.011. Epub 2010 Feb 13.

PMID:
20156514
4.

Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome.

Saletu M, Anderer P, Saletu-Zyhlarz GM, Parapatics S, Gruber G, Nia S, Saletu B.

J Neural Transm (Vienna). 2010 Apr;117(4):463-73. doi: 10.1007/s00702-009-0361-3. Epub 2010 Jan 5.

PMID:
20049491
5.

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.

Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.

Sleep Med. 2010 Jan;11(1):11-6. doi: 10.1016/j.sleep.2009.03.009. Epub 2009 Dec 4.

PMID:
19962941
6.

A randomized, double-blind, placebo-controlled, crossover study of XP13512/GSK1838262 in the treatment of patients with primary restless legs syndrome.

Kushida CA, Walters AS, Becker P, Thein SG, Perkins AT, Roth T, Canafax D, Barrett RW; XP021 Study Group.

Sleep. 2009 Feb;32(2):159-68.

7.

Double-blind, placebo-controlled, pilot trial of botulinum toxin A in restless legs syndrome.

Nahab FB, Peckham EL, Hallett M.

Neurology. 2008 Sep 16;71(12):950-1. doi: 10.1212/01.wnl.0000325994.93782.a1. No abstract available.

8.

The effect of endovenous laser ablation on restless legs syndrome.

Hayes CA, Kingsley JR, Hamby KR, Carlow J.

Phlebology. 2008;23(3):112-7. doi: 10.1258/phleb.2007.007051.

PMID:
18467618
9.

Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome.

Hornyak M, Rupp A, Riemann D, Feige B, Berger M, Voderholzer U.

Neurology. 2008 Apr 29;70(18):1620-2. doi: 10.1212/01.wnl.0000310984.45538.89.

PMID:
18443313
10.

Intradialytic aerobic exercise training ameliorates symptoms of restless legs syndrome and improves functional capacity in patients on hemodialysis: a pilot study.

Sakkas GK, Hadjigeorgiou GM, Karatzaferi C, Maridaki MD, Giannaki CD, Mertens PR, Rountas C, Vlychou M, Liakopoulos V, Stefanidis I.

ASAIO J. 2008 Mar-Apr;54(2):185-90. doi: 10.1097/MAT.0b013e3181641b07.

PMID:
18356653
11.

Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial.

Hornyak M, Grossmann C, Kohnen R, Schlatterer M, Richter H, Voderholzer U, Riemann D, Berger M.

J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):823-5. doi: 10.1136/jnnp.2007.138867. Epub 2008 Feb 26.

PMID:
18303103
12.

A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome.

Earley CJ, Horsk√° A, Mohamed MA, Barker PB, Beard JL, Allen RP.

Sleep Med. 2009 Feb;10(2):206-11. doi: 10.1016/j.sleep.2007.12.006. Epub 2008 Feb 14.

13.

Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.

Garcia-Borreguero D, Winkelman J, Adams A, Ellis A, Morris M, Lamb J, Layton G, Versavel M; Sumanirole in RLS Study Group.

Sleep Med. 2007 Mar;8(2):119-27. Epub 2007 Jan 18.

PMID:
17239657
15.

Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome.

Kutukcu Y, Dogruer E, Yetkin S, Ozgen F, Vural O, Aydin H.

Muscle Nerve. 2006 Jan;33(1):133-7.

PMID:
16175624
16.

Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.

Bliwise DL, Freeman A, Ingram CD, Rye DB, Chakravorty S, Watts RL.

Sleep Med. 2005 Mar;6(2):141-7.

PMID:
15716217
17.

Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study.

Micozkadioglu H, Ozdemir FN, Kut A, Sezer S, Saatci U, Haberal M.

Ren Fail. 2004 Jul;26(4):393-7.

PMID:
15462107
18.

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.

Allen R, Becker PM, Bogan R, Schmidt M, Kushida CA, Fry JM, Poceta JS, Winslow D.

Sleep. 2004 Aug 1;27(5):907-14.

PMID:
15453549
19.

Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release.

Pellecchia MT, Vitale C, Sabatini M, Longo K, Amboni M, Bonavita V, Barone P.

Clin Neuropharmacol. 2004 Jul-Aug;27(4):178-81.

PMID:
15319704
20.

Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study.

Trenkwalder C, Hundemer HP, Lledo A, Swieca J, Polo O, Wetter TC, Ferini-Strambi L, de Groen H, Quail D, Brandenburg U; PEARLS Study Group.

Neurology. 2004 Apr 27;62(8):1391-7.

PMID:
15111679

Supplemental Content

Support Center